Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Certara
Biotech
Gilman buckles in as Arrakis raises $75M—Chutes & Ladders
Gilman to be full-time CEO of Arrakis, while Wotton takes over Obsidian; ex-GSK immunology chief to lead Kintai Therapeutics; and Insys swaps CEOs.
Conor Hale
Apr 19, 2019 9:30am
Certara models aid 19 approvals as FDA pursues in silico tools
Aug 6, 2018 12:05pm
Certara breaks into real-world value services with Analytica Laser buy
Apr 18, 2018 8:01am
Chutes & Ladders—Novartis CEO Jimenez makes surprise exit
Sep 7, 2017 5:00pm
EQT to buy Certara from Arsenal for $850M
Jul 11, 2017 9:57am
